MTM Investment Management »

Sagimet Biosciences Inc-a shares owned by MTM Investment Management

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by MTM Investment Management from 13F filings

Historical chart of MTM Investment Management investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by MTM Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by MTM Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.8k 1.9k 5.23

More positions owned by MTM Investment Management

Apple (AAPL)
Lowe's Companies (LOW)
T Rowe Price Etf Inc Capital Appreciation Equity Cap Appreciation (TCAF)
JPMorgan Chase & Co. (JPM)
Amplify Cwp Enhanced Dividend Income Etf Cwp Enhanced Div (DIVO)
Eli Lilly & Co. (LLY)
McKesson Corporation (MCK)
Kinder Morgan (KMI)
Microsoft Corporation (MSFT)
Chevron Corporation (CVX)
Broadcom (AVGO)
Ishares Tr Rus 1000 Grw Etf Rus 1000 Grw Etf (IWF)
State Street Spdr S&p 500 Etf Trust Tr Unit (SPY)
Exxon Mobil Corporation (XOM)
Commerce Bancshares (CBSH)

View all positions for MTM Investment Management

Top funds holding Sagimet Biosciences Inc-a

Vanguard Group
Blue Owl Capital Holdings
Affinity Asset Advisors
Vanguard Capital Management
Woodline Partners
Baker Bros. Advisors
Millennium Management
BlackRock
Marshall Wace
Hillhouse Capital Advisors
Siren
D. E. Shaw & Co
Renaissance Technologies
Geode Capital Management
Hudson Bay Capital Management

View all funds holding Sagimet Biosciences Inc-a